JP2006528644A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528644A5
JP2006528644A5 JP2006521297A JP2006521297A JP2006528644A5 JP 2006528644 A5 JP2006528644 A5 JP 2006528644A5 JP 2006521297 A JP2006521297 A JP 2006521297A JP 2006521297 A JP2006521297 A JP 2006521297A JP 2006528644 A5 JP2006528644 A5 JP 2006528644A5
Authority
JP
Japan
Prior art keywords
stabilizer
oxidation state
water
cysteine
radiopharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006521297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528644A (ja
JP5139678B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/023930 external-priority patent/WO2005009393A2/en
Publication of JP2006528644A publication Critical patent/JP2006528644A/ja
Publication of JP2006528644A5 publication Critical patent/JP2006528644A5/ja
Application granted granted Critical
Publication of JP5139678B2 publication Critical patent/JP5139678B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006521297A 2003-07-24 2004-07-23 安定な放射性医薬品組成物およびその製法 Expired - Fee Related JP5139678B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48985003P 2003-07-24 2003-07-24
US60/489,850 2003-07-24
PCT/US2004/023930 WO2005009393A2 (en) 2003-07-24 2004-07-23 Stable radiopharmaceutical compositions and methods for preparation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012102165A Division JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Publications (3)

Publication Number Publication Date
JP2006528644A JP2006528644A (ja) 2006-12-21
JP2006528644A5 true JP2006528644A5 (enExample) 2009-12-10
JP5139678B2 JP5139678B2 (ja) 2013-02-06

Family

ID=34102942

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006521297A Expired - Fee Related JP5139678B2 (ja) 2003-07-24 2004-07-23 安定な放射性医薬品組成物およびその製法
JP2012102165A Withdrawn JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012102165A Withdrawn JP2012158600A (ja) 2003-07-24 2012-04-27 安定な放射性医薬品組成物およびその製法

Country Status (13)

Country Link
US (3) US20070269375A1 (enExample)
EP (1) EP1654005A4 (enExample)
JP (2) JP5139678B2 (enExample)
KR (1) KR101106533B1 (enExample)
CN (1) CN100418585C (enExample)
AU (1) AU2004259028C1 (enExample)
BR (1) BRPI0412824A (enExample)
CA (2) CA2526556C (enExample)
IL (1) IL172059A0 (enExample)
RU (1) RU2006105644A (enExample)
SG (2) SG177216A1 (enExample)
WO (1) WO2005009393A2 (enExample)
ZA (1) ZA200509666B (enExample)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) * 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
GB0514087D0 (en) * 2005-07-11 2005-08-17 Ge Healthcare Ltd Stabilised radiopharmaceutical compositions
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US8926945B2 (en) 2005-10-07 2015-01-06 Guerbet Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
US20100056826A1 (en) * 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
AU2007343610C1 (en) * 2007-01-17 2013-11-07 Immunomedics, Inc. Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
EP2170268A2 (en) 2007-06-25 2010-04-07 Amgen, Inc. Compositions of specific binding agents to hepatocyte growth factor
MX2010005122A (es) * 2007-11-07 2010-08-18 Ge Healthcare Bv Estabilizacion de radiofarmaceuticos.
WO2009108376A2 (en) 2008-02-29 2009-09-03 Lantheus Medical Imaging, Inc. Contrast agents for applications including perfusion imaging
EP2100900A1 (en) * 2008-03-07 2009-09-16 Universitätsspital Basel Bombesin analog peptide antagonist conjugates
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
US20120045393A1 (en) 2009-03-17 2012-02-23 Linder Karen E Lhrh-ii peptide analogs
WO2010121133A2 (en) 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
CN102356087A (zh) 2009-03-19 2012-02-15 惠氏有限责任公司 [2-(8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1(7)-烯-2-基)乙基]膦酸及其前体的制备方法
KR20160030589A (ko) 2009-04-15 2016-03-18 랜티우스 메디컬 이메징, 인크. 아스코르브산을 사용한 방사성 약제 조성물의 안정화
WO2011066521A2 (en) 2009-11-30 2011-06-03 Stc. Unm Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
EP2518086A1 (en) * 2009-12-25 2012-10-31 Riken Radiolabeled compound directable in vivo to target tissue and use thereof
DK3323810T3 (da) 2010-02-08 2022-03-28 Lantheus Medical Imaging Inc Automatiseret reaktionssystem, kassette og indretning til syntese af billeddannelsesmidler
CN101786990B (zh) * 2010-03-04 2012-01-18 合肥工业大学 一种具有抗痒活性的化合物
US9240253B2 (en) * 2010-04-07 2016-01-19 Ge-Hitachi Nuclear Energy Americas Llc Column geometry to maximize elution efficiencies for molybdenum-99
DE102010026052A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines krankhaften Gewebes, das einen IGF-Rezeptor exprimiert
DE102010026060A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Somatostatinrezeptor exprimiert
DE102010026065A1 (de) * 2010-06-30 2012-01-05 Siemens Aktiengesellschaft 11C-markiertes Peptid zur Detektion eines Tumors, der einen Bombesin-Rezeptor exprimiert
WO2012021882A2 (en) 2010-08-13 2012-02-16 Siemens Medical Solutions Usa, Inc. Formulation, apparatus and method for stabilizing radiopharmaceuticals
ITFI20110180A1 (it) 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
KR102006599B1 (ko) * 2011-12-21 2019-08-01 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
CN109966515A (zh) * 2011-12-21 2019-07-05 通用电气健康护理有限公司 在柠檬酸盐缓冲液中的18F-Fluciclovine组合物
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
CN102552949B (zh) * 2012-02-21 2013-07-10 安徽筑梦生物科技有限公司 99mTc标记RGD多肽肿瘤诊断药物及其制备方法
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2014040192A1 (en) * 2012-09-13 2014-03-20 British Columbia Cancer Agency Branch Compositions targeting bradykinin receptor b1 for medical imaging of cancer and other disorders
ES2745635T3 (es) 2012-09-25 2020-03-03 Advanced Accelerator Applications Usa Inc Antagonistas de GRPR para la detección, diagnóstico y tratamiento del cáncer positivo para GRPR
RU2528414C1 (ru) * 2013-01-25 2014-09-20 Закрытое Акционерное Общество "Фарм-Синтез" Циклический октапептид, радиофармацевтическое средство на его основе и способ применения радиофармацевтического средства для получения лекарственных (фармацевтических) средств для лечения новообразований, экспрессирующих соматостатиновые рецепторы
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
WO2014151411A1 (en) 2013-03-15 2014-09-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
EP2821383B1 (en) * 2013-07-02 2017-08-30 Trasis S.A. Stabilization of radiosynthetic intermediates
JP6410339B2 (ja) * 2013-03-25 2018-10-24 国立大学法人千葉大学 放射性核種標識オクトレオチド誘導体
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
KR101523249B1 (ko) 2014-05-22 2015-05-27 서울대학교산학협력단 엑소좀을 방사성 물질로 표지하는 방법 및 그 용도
KR101658201B1 (ko) * 2014-06-16 2016-09-22 한국원자력연구원 전립선암의 진단 및 치료를 위한 가스트린유리펩티드수용체 작용서열 기반의 신규한 봄베신 유도체 화합물
US10227376B2 (en) * 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
IL237525A (en) 2015-03-03 2017-05-29 Shalom Eli Method for labeling a prostate-specific membrane antigen with a radioactive isotope
JP6527736B2 (ja) * 2015-03-30 2019-06-05 富士フイルム富山化学株式会社 放射性医薬組成物
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
WO2017161356A1 (en) 2016-03-18 2017-09-21 Wake Forest University Compounds, compositions and associated methods using zirconium-89 in immuno-positron emission tomography
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity
WO2018204872A2 (en) * 2017-05-05 2018-11-08 Fusion Pharmaceuticals Inc. Igf-1r monoclonal antibodies and uses thereof
DK3459526T3 (da) * 2017-09-26 2021-05-25 Palacky Univ In Olomouc Biotilgængelige dithiocarbamat-metalkompleks-nanopartikler, fremgangsmåde til fremstilling og anvendelse deraf
US12582729B2 (en) 2018-01-26 2026-03-24 Wake Forest University Health Sciences Kit technology for the production and long-term storage of Zr-89-PET radiopharmaceuticals
CN112423744A (zh) * 2018-04-11 2021-02-26 透明医药有限公司 用于放射疗法和诊断成像的制剂和试剂盒
US10596276B2 (en) 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
LT4541381T (lt) * 2018-07-25 2026-03-25 Advanced Accelerator Applications S.A. Stabilūs, koncentruoti radionuklidų kompleksų tirpalai
WO2020021310A1 (en) * 2018-07-25 2020-01-30 Advanced Accelerator Applications (Italy) Srl Stable, concentrated radionuclide complex solutions
US10596278B2 (en) * 2018-07-25 2020-03-24 Advanced Accelerator Applications (Italy) S.R.L. Stable, concentrated radionuclide complex solutions
WO2020202831A1 (ja) * 2019-03-29 2020-10-08 国立研究開発法人量子科学技術研究開発機構 放射性医薬の製造方法及び放射性医薬
US12186328B2 (en) 2019-05-23 2025-01-07 Brigham Young University Use of CSA compounds to stimulate stem cells and hair growth
KR20220063218A (ko) * 2019-09-16 2022-05-17 노파르티스 아게 안정한 농축 방사성 약제학적 조성물
TWI878344B (zh) * 2019-09-17 2025-04-01 瑞士商諾華公司 放射性標記grpr拮抗劑之方法及其套組
KR102207372B1 (ko) * 2020-03-31 2021-01-27 재단법인 아산사회복지재단 방사성 의약품의 안정화제 및 이를 포함하는 방사성 의약 조성물
CN116547007A (zh) * 2020-07-13 2023-08-04 普安生物制药有限公司 放射性药物和方法
EP4178628A4 (en) 2020-07-13 2025-04-02 Point Biopharma, Inc. RADIOPHARMACEUTICALS AND PROCEDURES
US11129912B1 (en) * 2020-07-13 2021-09-28 POINT Biopharma Inc. Radiopharmaceutical and methods
CA3190855A1 (en) 2020-08-27 2022-03-03 Joe Mccann Radiopharmaceutical and methods
AU2021359638A1 (en) * 2020-10-14 2023-06-01 Centenary Institute Of Cancer Medicine And Cell Biology Therapeutic radiolabelled conjugates and their use in therapy
WO2022111800A1 (en) * 2020-11-25 2022-06-02 Itm Solucin Gmbh Stable formulations for radionuclide complexes
CN112546247A (zh) * 2020-12-03 2021-03-26 西南医科大学附属医院 多羟基苯酚类化合物的应用、放射性药物组合物及制法
WO2022156907A1 (en) 2021-01-25 2022-07-28 Vrije Universiteit Brussel Method and kit for labeling a biomolecule with one or more detectable labels, including a radiolabel
BE1027699B1 (fr) * 2021-01-28 2022-04-01 Trasis S A Procédé de purification de macro-agrégats de sérumalbumine humaine radiomarqués
CN112999369B (zh) * 2021-03-03 2022-02-25 江苏元本生物科技有限公司 一种her2亲合体放射性核素标记物组合物及其应用
WO2022251516A2 (en) * 2021-05-26 2022-12-01 Cornell University Complexes with acyclic chelators and their use in targeted radiotherapy of cancer
CA3227042A1 (en) * 2021-08-02 2023-10-05 Daniel Kim Stabilized compositions of radionuclides and uses thereof
EP4442285A1 (en) * 2021-11-30 2024-10-09 Nihon Medi-Physics Co., Ltd. Stabilized radiopharmaceutical composition
CN116920129A (zh) * 2022-04-02 2023-10-24 北京先通国际医药科技股份有限公司 放射性药物水溶液及其制备方法和用途
CN116920128A (zh) * 2022-04-02 2023-10-24 北京先通国际医药科技股份有限公司 一种放射性药物水溶液及其用途
CN115015441B (zh) * 2022-07-14 2023-08-18 原子高科股份有限公司 一种测定镥[177Lu]氧奥曲肽注射液中稳定剂含量的方法
CA3263646A1 (en) * 2022-07-29 2024-07-18 Curium Us Llc [177lu] lutetium-psma l&t composition, kit, method of making, and method of using thereof
WO2025029946A1 (en) 2023-07-31 2025-02-06 Curium Us Llc [177lu] lutetium-psma i&t composition and dosimetry, kit, method of making, and method of using thereof
WO2026008525A1 (en) * 2024-07-01 2026-01-08 Bayer Aktiengesellschaft Stable radionuclide-containing formulations

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441184A (en) * 1890-11-25 Car-coupling
US441181A (en) * 1890-11-25 Making peptonized meat
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
US4416865A (en) * 1973-02-20 1983-11-22 Research Corporation Radiopharmaceuticals for localization of thromboembolic disease
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
US4075314A (en) * 1976-04-29 1978-02-21 Mallinckrodt, Inc. Stannous pyrophosphate technetium-99m compositions
US4232000A (en) * 1978-06-28 1980-11-04 The Procter & Gamble Company Radioactive scanning agents with stabilizer
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
EP0063946A1 (en) * 1981-04-21 1982-11-03 AMERSHAM INTERNATIONAL plc Diagnosis of kidney function
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3274621D1 (en) * 1981-10-30 1987-01-22 Amersham Int Plc Radiopharmaceutical composition based on technetium-99m and reagent for making it
US4440738A (en) * 1982-06-10 1984-04-03 Mallinckrodt, Inc. Stable radiographic imaging agents
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
US4510125A (en) * 1982-12-08 1985-04-09 Mallinckrodt, Inc. Process for making lyophilized radiographic imaging kit
US4707353A (en) * 1982-12-08 1987-11-17 Mallinckrodt, Inc. Radiographic imaging agents
JPS59199636A (ja) * 1983-04-26 1984-11-12 Nippon Mejifuijitsukusu Kk 放射性診断剤
JPS6058927A (ja) * 1983-09-09 1985-04-05 Nippon Mejifuijitsukusu Kk 放射能標識血小板製剤
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4899755A (en) * 1985-05-08 1990-02-13 The General Hospital Corporation Hepatobiliary NMR contrast agents
MX174467B (es) * 1986-01-23 1994-05-17 Squibb & Sons Inc 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
US4808705A (en) * 1986-12-19 1989-02-28 Cetus Corporation Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5021556A (en) * 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
US5128119A (en) * 1989-06-12 1992-07-07 Immunomedics, Inc. Methods for technetium/rhenium labeling of f(ab1)2 fragments
US5075099A (en) * 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5169933A (en) * 1988-08-15 1992-12-08 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
EP0438527A4 (en) * 1988-10-14 1992-07-01 Mallinckrodt, Inc. Radiolabelled particulate composition
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5262175A (en) * 1989-05-10 1993-11-16 Solanki Kishor K Stabilization of radiopharmaceutical compositions
US5118797A (en) * 1989-08-28 1992-06-02 E. R. Squibb & Sons, Inc. Rhenium tris dioxime complexes
CA2034042C (en) * 1990-01-18 1999-08-17 Adrian D. Nunn Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group
US5183653A (en) * 1990-04-13 1993-02-02 E. R. Squibb & Sons, Inc. Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes
GB9019195D0 (en) * 1990-09-03 1990-10-17 Shell Int Research Cyclohexenol derivatives
JP2860157B2 (ja) * 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5367080A (en) * 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
DK0600992T3 (da) * 1991-08-29 2000-10-09 Mallinckrodt Medical Inc Anvendelse af gentissyre eller gentisylalkohol til stabilisering af radiomærkede peptider og proteiner
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
US5750088A (en) * 1993-03-30 1998-05-12 The Dupont Merck Pharmaceutical Company Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
US5608110A (en) * 1993-06-15 1997-03-04 Bracco International B.V. Heteroatom-bearing ligands and metal complexes thereof
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US6066309A (en) * 1996-02-02 2000-05-23 Rhomed Incorporated Post-labeling stabilization of radiolabeled proteins and peptides
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6027710A (en) * 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
EP0977579B1 (en) * 1997-04-22 2009-03-11 Curator Of The University Of Missouri Gastrin receptor-avid peptide conjugates
CA2346154A1 (en) * 2001-05-02 2002-11-02 University Of Missouri Gastrin receptor-avid peptide conjugates
US5886142A (en) * 1997-05-20 1999-03-23 Thomas Jefferson University Radiolabeled thrombus imaging agents
DE69811680T2 (de) * 1997-08-14 2003-10-16 Daiichi Radioisotope Laboratories Ltd., Tokio/Tokyo Stabile radioaktive medikamente
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
GB0015242D0 (en) * 2000-06-22 2000-08-16 Nycomed Amersham Plc Stabiliser for radiopharmaceuticals
CA2413538A1 (en) * 2000-07-06 2002-01-17 Bristol-Myers Squibb Pharma Company Stable radiopharmaceutical compositions and methods for preparation thereof
DE60136073D1 (de) * 2000-07-28 2008-11-20 Nihon Mediphysics Co Ltd Technitium-99m nitrid hetero-komplex radiopharmazeutisches mittel zur bilderzeugung
US6989138B2 (en) * 2000-10-24 2006-01-24 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans
FR2817259B1 (fr) * 2000-11-29 2003-02-21 Cis Bio Int Compose de chelation d'un metal, radiopharmaceutique, procede de fabrication de ceux-ci et trousse de diagnostic
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
CA2485339C (en) * 2002-05-03 2012-02-14 Bracco Imaging S.P.A. Radiopharmaceutical formulations
US7226577B2 (en) * 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds

Similar Documents

Publication Publication Date Title
JP2006528644A5 (enExample)
CA2526556A1 (en) Stable radiopharmaceutical compositions and methods for their preparation
Sadler et al. The chemistry of gold drugs
JP2022110118A (ja) Ｐｓｍａ結合性リガンド－リンカー結合体及び使用方法
JP2004529884A5 (enExample)
ES2624626T3 (es) Ligadores basados en tirosina para la conexión desprendible de péptidos
US7045503B1 (en) Radiometal-binding peptide analogues
JP3054346B2 (ja) ペプチド類
HU219336B (en) Process for producing peptide derivatives and pharmaceutical compositions comprising such compounds and diagnostic unit containing such compounds
NZ587795A (en) Bombesin analog peptide antagonist conjugates
DE69837038T2 (de) Tetraaza- oder n2s2-komplexanten, und deren verwendung in der radiodiagnostik oder radiotherapie
JP4885448B2 (ja) 放射性医薬品製剤（ｒａｄｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｆｏｒｍｕｌａｔｉｏｎｓ）
JP6231882B2 (ja) 放射性コンジュゲーション方法
CA3148288A1 (en) Method for producing radioactive metal complex
US20090062509A1 (en) Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines
AU698824B2 (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
HUT73489A (en) Chelators of type xn1s1x' braked with twovalent calcogene atom for radioactive isotopes, their metal complexes and their diagnostic and therpeutical uses, and pharmaceutical compositions containing them, and process for producing them
EP4455159A1 (en) Gastric inhibitory peptide receptor ligands with bio-distribution modifier
KR20210121959A (ko) 혈전영상을 위한 방사성의약품 및 조성물
EP2710027A1 (en) Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents
EP0759913A1 (en) Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
KR100567001B1 (ko) 시스테인 유도체 및 이를 이용한 금속 트리카보닐 착화물,이들의 제조 방법 및 이들을 포함하는 조영제
RU2006126637A (ru) Улучшенные производные пептида, высвобождающего гастрит